Carcinoma, Lobular: all 69 studies
Page 1 of 1. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- FES PET/MRI for Occult Disease in Lobular Breast CancerRecruitingNCT07910474Phase 4
- [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsRecruitingNCT07702292Phase 2
- Disease Extent in Stage IV Lobular Carcinoma: the Aid of Imaging and Liquid Biopsy AnalysesNot yet recruitingNCT07635654Not applicable
- Negative/Low Hormone Receptor And/or HER2 POsitive Lobular Invasive Breast Carcinoma - A Real-World International Cohort StudyRecruitingNCT07613151
- HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving SurgeryNot yet recruitingNCT07527468Not applicable
- A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast CancerRecruitingNCT07483307Phase 2
- [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsRecruitingNCT07432633Phase 1/2
- [68]GA-FAPI-46 PET/CT for the Diagnosis of Metastatic Lesions in Patients With Lobular Breast Cancer (ICL).Not yet recruitingNCT07313033Not applicable
- A Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular CarcinomaRecruitingNCT07229417Phase 2
- [68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)RecruitingNCT07020806Phase 1
- Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast CancerRecruitingNCT06666439
- Biomarkers to Detect Endocrine Therapy ResistanceRecruitingNCT06067503Phase 2
- 18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast CancerRecruitingNCT05982496Phase 2
- Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)RecruitingNCT05964504
- Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast CancersRecruitingNCT05919108Phase 2
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueRecruitingNCT05837767Not applicable
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruitingNCT05463796
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsRecruitingNCT05269381Phase 1/2
- Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast CancerCompletedNCT04750473Phase 1Results posted
- [18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular CarcinomaTerminatedNCT04252859Phase 2Results posted
- Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid TumoursCompletedNCT03620643Phase 2Results posted
- Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerActive, not recruitingNCT03414970Phase 3Results posted
- Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)Active, not recruitingNCT02764541Phase 2Results posted
- Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast CancerTerminatedNCT02137252Phase 2Results posted
- Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation TherapyCompletedNCT01819233Not applicableResults posted
- Accelerated Radiation Therapy After Surgery in Treating Patients With Breast CancerCompletedNCT01417286Phase 2Results posted
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving SurgeryCompletedNCT01082211Phase 2Results posted
- Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast CancerActive, not recruitingNCT00616967Phase 2Results posted
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast CancerCompletedNCT00304096Phase 1Results posted
- Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast CancerActive, not recruitingNCT00295893Phase 2Results posted
- Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerCompletedNCT00182793Phase 2Results posted
- Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast CancerCompletedNCT00058058Not applicableResults posted
- AI-based Prognostic Factors Identification in Early-stage Invasive Lobular Breast CarcinomaCompletedNCT07842055
- A Study Comparing Cancer Imaging Approaches in People With Lobular Breast CancerActive, not recruitingNCT06557148
- Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)TerminatedNCT06408168Phase 2
- Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health SystemCompletedNCT06133647
- Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular CarcinomaCompletedNCT05960201Phase 2
- Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CTActive, not recruitingNCT05931302Not applicable
- LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer PatientsActive, not recruitingNCT05410951
- Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)Active, not recruitingNCT04551495Phase 2
- CDH1 Germline Mutations in Lobular Breast CancerCompletedNCT04206891
- Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast CancerStatus unknownNCT04021069
- Living Well After Breast SurgeryCompletedNCT03834532Not applicable
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryActive, not recruitingNCT01953588Phase 3
- Intraoperative Imaging of Breast Cancer With Indocyanine GreenCompletedNCT01796041Early Phase 1
- Broccoli Sprout Extract in Treating Patients With Breast CancerCompletedNCT01753908Early Phase 1
- Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT01706432
- Single Fraction Intraoperative RadiotherapyCompletedNCT01688388Not applicable
- "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"Status unknownNCT01641406Phase 2
- Fast Spectral Imaging Device for Tumor Margin MappingCompletedNCT01107080
- Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast CancerWithdrawnNCT01100489Phase 2
- To Evaluate the Characteristics of a Breast CancerWithdrawnNCT01055678Early Phase 1
- Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer TherapyStatus unknownNCT01038258Not applicable
- Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2Status unknownNCT00967239
- Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast CancerCompletedNCT00960336Phase 2
- Radiation Therapy in Treating Women With Early Stage Breast CancerActive, not recruitingNCT00909909Phase 2
- Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast DiseaseCompletedNCT00898508
- Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00859157
- 11C-Acetate PET/CT Non-FDG-Avid TumorsStatus unknownNCT00687778
- Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast CancerCompletedNCT00599989Not applicable
- Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in SituCompletedNCT00581750
- Genetics of Women With Lobular Carcinoma in Situ of the BreastStatus unknownNCT00536718
- Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesCompletedNCT00433589Phase 3
- Radiation Therapy in Treating Women With Invasive Breast CancerCompletedNCT00301041Early Phase 1
- Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast CancerTerminatedNCT00267553Phase 3
- The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerTerminatedNCT00097344Phase 3
- Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast CancerCompletedNCT00096343Phase 2
- Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast CancerCompletedNCT00084669Not applicable
- Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerCompletedNCT00044291Phase 3